Teladoc (TDOC) Hits New 12-Month High at $38.55

Teladoc Inc (NYSE:TDOC) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $38.55 and last traded at $38.55, with a volume of 537007 shares. The stock had previously closed at $37.15.

Several research firms recently issued reports on TDOC. Jefferies Group began coverage on shares of Teladoc in a research report on Friday, January 26th. They issued a “buy” rating and a $40.00 target price on the stock. CIBC reissued an “outperform” rating and issued a $45.00 target price (up from $40.00) on shares of Teladoc in a research report on Tuesday, November 21st. ValuEngine raised shares of Teladoc from a “sell” rating to a “hold” rating in a research report on Friday, February 2nd. Canaccord Genuity set a $42.00 target price on shares of Teladoc and gave the stock a “buy” rating in a research report on Friday, November 17th. Finally, KeyCorp reaffirmed a “buy” rating and set a $39.00 price target on shares of Teladoc in a research report on Monday, December 4th. One analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $39.43.

The firm has a market capitalization of $2,119.38, a P/E ratio of -27.05 and a beta of 0.49. The company has a debt-to-equity ratio of 0.83, a quick ratio of 5.08 and a current ratio of 5.08.

In other news, CEO Jason N. Gorevic sold 100,000 shares of Teladoc stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $32.99, for a total transaction of $3,299,000.00. Following the sale, the chief executive officer now owns 718,261 shares in the company, valued at $23,695,430.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Mark Hirschhorn sold 30,000 shares of Teladoc stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $32.99, for a total transaction of $989,700.00. Following the sale, the chief financial officer now owns 5,203 shares in the company, valued at approximately $171,646.97. The disclosure for this sale can be found here. Company insiders own 4.47% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of TDOC. BlackRock Inc. increased its stake in shares of Teladoc by 7.4% in the fourth quarter. BlackRock Inc. now owns 4,971,297 shares of the health services provider’s stock worth $173,252,000 after buying an additional 342,715 shares during the last quarter. Alliancebernstein L.P. increased its stake in Teladoc by 15.7% during the fourth quarter. Alliancebernstein L.P. now owns 4,472,612 shares of the health services provider’s stock valued at $155,871,000 after purchasing an additional 607,002 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Teladoc by 24.4% during the third quarter. JPMorgan Chase & Co. now owns 3,313,729 shares of the health services provider’s stock valued at $108,193,000 after purchasing an additional 650,129 shares during the last quarter. Vanguard Group Inc. increased its stake in Teladoc by 11.5% during the second quarter. Vanguard Group Inc. now owns 3,041,725 shares of the health services provider’s stock valued at $105,547,000 after purchasing an additional 314,646 shares during the last quarter. Finally, Eagle Asset Management Inc. increased its stake in Teladoc by 16.3% during the fourth quarter. Eagle Asset Management Inc. now owns 2,449,900 shares of the health services provider’s stock valued at $85,358,000 after purchasing an additional 343,070 shares during the last quarter.

ILLEGAL ACTIVITY WARNING: “Teladoc (TDOC) Hits New 12-Month High at $38.55” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/20/teladoc-tdoc-hits-new-12-month-high-at-38-55.html.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply